We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 861

Resource type: Peer-reviewed journal

Page 37 of 44
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

This study, published in the New England Journal of Medicine, assessed the feasibility of integrating the RTS,S/AS02D malaria vaccine into a standard expanded program on immunization (EPI) schedule for infants. The study, conducted in …

Author: Abdulla S, Oberholzer R, Juma O, et al.

Publication date: 2008

Safety, Immunogenicity, and Antibody Persistence of a New Meningococcal Group A Conjugate Vaccine in Healthy Indian Adults

This article, published in the journal Vaccine, discusses a double-blind, randomized, controlled Phase 1 study in India to assess safety, immunogenicity, and antibody persistence of the new meningococcal group A conjugate vaccine (PsA-TT) in …

Author: Kshirsagar N, Mur N, Thatte U, et al.

Publication date: 2007

Safety, Immunogenicity and Efficacy of Pneumococcal Conjugate Vaccine in HIV-Infected Individuals

This article, published in Human Vaccines & Immunotherapeutics, summarizes the available published data on the immunogenicity, safety, and efficacy of pneumococcal polysaccharide-protein conjugate vaccines in HIV-infected children and adults.

Author: Nunes MC, Madhi SA

Publication date: 2012

Safety of Immunization Injections in Africa: Not Simply a Problem of Logistics

From the Bulletin of the World Health Organization, this report is an evaluation of a "logistic approach" on immunization injection safety. The investigators found that unsafe injection practices were generally due to a failure to integrate …

Author: Dicko M, Oni AQ, Ganivet S, et al.

Publication date: 2000

Safety of Russian-Backbone Seasonal Trivalent, Live-Attenuated Influenza Vaccine in a Phase II Randomized Placebo-Controlled Clinical Trial Among Children in Urban Bangladesh

This article, published in Vaccine, reports the results of a study to evaluate the safety of a Russian-backbone, seasonal trivalent, live-attenuated influenza vaccine (LAIV) in children aged 24 through 59 months in Bangladesh. The authors found that …

Author: Ortiz JR, Goswami D, Lewis KDC, et al.

Publication date: 2015

Safety of the RTS,S/AS02A Malaria Vaccine in Mozambican Children During a Phase IIb Trial

This study, published in the journal Vaccine, evaluated the safety of the RTS,S/AS02A malaria vaccine in a proof of concept Phase IIb trial in Mozambican children aged one to four years. Overall, the study results indicate that the …

Author: Sacarlal J, Aponte JJ, Aide P, et al.

Publication date: 2008

Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review

This article, published in Pediatrics, reviews the existing literature on the safety of routine vaccines recommended for children in the United States. The authors found evidence that some vaccines are associated with serious adverse events; …

Author: Maglione MA, Das L, Raaen L, et al.

Publication date: 2014

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

This article, published in Pediatrics, evaluated the overall safety profile of the 9-valent human papillomavirus (9vHPV) vaccine across seven Phase 3 studies in 9 to 26 year old males and females (nonpregnant at entry). The authors found that the …

Author: Moreira ED, Block SL, Ferris D, et al.

Publication date: 2016

Safety, Tolerability, and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process

This article, published in the Pediatric Infectious Disease Journal, describes the results of a Phase 3 study of a modified formulation of RotaTeq® (RV5) rotavirus vaccine that was developed to be stable at 37°C for 7 days and that has an …

Author: Martinón-Torres F, Dionne M, Greenberg D, et al.

Publication date: 2017

A School-Based Human Papillomavirus Vaccination Program in Barretos, Brazil: Final Results of a Demonstrative Study

This article, published in PLoS ONE, reports on a study to evaluate the uptake and three-dose completion rates of a school-based human papillomavirus (HPV) vaccination program in Brazil. The results showed high rates of vaccination uptake and …

Author: Fregnani JHTG, Carvalho AL, Eluf-Neto J, et al.

Publication date: 2013

Scientific Barriers to Developing Vaccines Against Avian Influenza Viruses

This review, published in Nature Reviews Immunology, discusses gaps in the knowledge of how avian influenza viruses work in humans and the the status of influenza vaccine development as of 2007. It also provides a general overview of the features of …

Author: Subbarao K, Joseph T

Publication date: 2007

Seasonal Influenza Vaccine Provision in 157 Countries (2004-2009) and the Potential Influence of National Public Health Policies

This article, published in Vaccine, details the results of a survey of global influenza vaccine supply covering 157 countries from 2004 to 2009. The authors find that global annual vaccine provision increased 72 percent to 449 million doses during …

Author: Palache A

Publication date: 2011

Seasonality of Meningitis in Africa and Climate Forcing: Aerosols Stand Out

The determinants of the disease dynamics of bacterial meningitis in the African meningitis belt are still poorly understood; nevertheless, it is often advocated that climate and mineral dust have a large impact. Several studies have investigated …

Author: Agier L, Deroubaix A, Martiny N, Yaka P, Djibo A, Broutin H

Publication date: 2013

Sequelae of Epidemic Meningococcal Meningitis in Africa

This article, published in Transactions of the Royal Society of Tropical Medicine and Hygiene, reviews audiological and other long-term neurological sequelae in 157 cases and their controls 6 to 12 months after an epidemic of group A meningococcal …

Author: Smith AW, Bradley AK, Wall RA, et al.

Publication date: 1988

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

This article, published in The Journal of Infectious Diseases, examines the antigenic distance hypothesis (AHD) in the context of serial influenza vaccination in Canada. The study found that the effects of repeat influenza vaccination varied …

Author: Skowronski DM, Chambers C, De Serres G, et al.

Publication date: 2017

Serogroup W135 Meningococcal Disease, The Gambia, 2012

This article, published in Emerging Infectious Diseases, reports on a 2012 outbreak of Neisseria meningitidis serogroup W135 which occurred in The Gambia. The attack rate was highest among young children. The associated risk factors were male sex, …

Author: Hossain MJ, Roca A, Mackenzie GA, et al.

Publication date: 2013

Serotype-Independent Pneumococcal Vaccines

This article, published in Cellular and Molecular Life Sciences, discusses the most promising vaccine approaches for inducing serotype-independent immunity, including protein antigens, whole cell pneumococcal vaccines, and recombinant bacteria …

Author: Miyaji EN, Oliveira MLS, Carvalho E, Ho PL

Publication date: 2013

Serum and Mucosal Antibody Responses to Inactivated Polio Vaccine After Sublingual Immunization Using a Thermoresponsive Gel Delivery System

This article, published in Human Vaccines & Immunotherapeutics, reports on a preclinical study of an adjuvanted thermoresponsive gel (TRG) presentation of trivalent inactivated poliovirus vaccine to achieve sublingual immunization. This TRG …

Author: White JA, Blum JS, Hosken NA, et al.

Publication date: 2014

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

This article, published in Clinical Infectious Diseases, reports on the Shigella serotypes identified in the Global Enteric Multicenter Study conducted in Africa and Asia in order to guide vaccine development efforts. The authors found that Shigella …

Author: Livio S, Strockbine NA, Panchalingam S, et al.

Publication date: 2014

A Shigella Vaccine Against Prevalent Serotypes

This article, published in Clinical Infectious Diseases, discusses the case for development of a pediatric vaccine against Shigella, which is a leading cause of diarrheal disease among children aged 12 to 59 months. The authors provide an analysis …

Author: Van de Verg LL, Venkatesan MM

Publication date: 2014

Page 37 of 44